Inventor · disambiguated record
Andreas Gollner
Also filed as: GOLLNER ANDREAS
17 granted patents·13 pending applications·57 citations·filing 2002–2024
91Inventor score
Files withBOEHRINGER INGELHEIM INT21BOEHRINGER INGELHEIM INTL GMBH CORP4CYTEC SURFACE SPECIALTIES AT1GEISBERGER MARTIN1SNYDER SCOTT ALAN1
Top patents by PatentIndex Score
30 records- 0189US12312363B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2023·Granted May 27, 2025·0 cites·4 claims
- 0289US10695334B2Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Jun 30, 2020·4 cites·25 claims
- 0389US10144739B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Dec 4, 2018·9 cites·65 claims
- 0488US10246467B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Apr 2, 2019·9 cites·17 claims
- 0585US10138251B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Nov 27, 2018·6 cites·12 claims
- 0683US10501440B2Heteroarylcarboxamide derivatives as plasma kallikrein inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Dec 10, 2019·4 cites·14 claims
- 0780US6653369B2Water dilutable amine curing agents for aqueous two component epoxy resin systemsSOLUTIA AUSTRIA GMBH·Filed 2002·Granted Nov 25, 2003·22 cites·24 claims
- 0879US10919913B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Feb 16, 2021·2 cites·18 claims
- 0978USRE50594ESpiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2023·Granted Sep 23, 2025·0 cites·15 claims
- 1067US2021101912A1New spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 1166US10576064B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Mar 3, 2020·1 cites·10 claims
- 1264US10882866B1Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Jan 5, 2021·0 cites·2 claims
- 1364US2025163039A1Heteroaromatic compounds for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1462US12060367B2Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2023·Granted Aug 13, 2024·0 cites·49 claims
- 1562US2025002504A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1661US2025019385A1Spirocyclic annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1758US11945812B2Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2021·Granted Apr 2, 2024·0 cites·39 claims
- 1858US10717742B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Jul 21, 2020·0 cites·1 claims
- 1956US2023227470A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 2055US2025313553A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 2154US2025296940A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 2253US2025129096A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 2352US2025145608A1Kras degrading compounds comprising annulated 2-amino-3-cyano thiophenesBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 2451US12281099B2Isoindolinone substituted indoles and derivatives as RAS inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Apr 22, 2025·0 cites·3 claims
- 2551US12091399B2Phenyltetrazole derivatives as plasma kallikrein inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Sep 17, 2024·0 cites·14 claims
- 2649US2018291030A1New spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 2742US2008200599A1Aqueous Epoxy Resin SystemsCYTEC SURFACE SPECIALTIES AT·Filed 2005·Application pending·0 cites
- 2841US2004180992A1Epoxy resin compositionsSURFACE SPECIALTIES AUSTRIA·Filed 2004·Application pending·0 cites
- 2936US9012536B2Water-borne paints based on epoxy resinsGEISBERGER MARTIN·Filed 2008·Granted Apr 21, 2015·0 cites·11 claims
- 3028US2014243404A1Unique halogen-induced cyclizations, reagents therefor, and compounds produced therebySNYDER SCOTT ALAN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andreas Gollner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →